Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study

Wang, JT; Zhang, QR; Ai, JW; Liu, DX; Liu, CA; Xiang, HL; Gu, Y; Guo, Y; Lv, JJ; Huang, YF; Liu, YN; Xu, D; Chen, SB; Li, JL; Li, QQ; Liang, J; Bian, L; Zhang, Z; Guo, XQ; Feng, YN; Liu, LX; Zhang, XY; Zhang, YL; Xie, FR; Jiang, SJ; Qin, W; Wang, XD; Rao, W; Zhang, Q; Tian, QJ; Zhu, Y; Cong, QW; Xu, J; Hou, ZY; Zhang, NN; Zhang, AG; Zu, HM; Wang, Y; Yan, ZL; Du, XF; Hou, AF; Yan, Y; Qiu, YW; Wu, HY; Hu, SJ; Deng, YH; Ji, JS; Yang, J; Huang, JS; Zhao, ZW; Zou, SQ; Ji, HL; Ge, GH; Zhong, L; He, S; Yan, XS; Yangzhen, BB; Qu, C; Zhang, LT; Yang, SY; Gao, XQ; Lv, MH; Zhu, QL; Xu, XX; Zeng, QL; Qi, XL; Zhang, WH

Qi, XL (通讯作者),Southeast Univ, Zhongda Hosp, Sch Med, Dept Radiol, Nanjing, Jiangsu, Peoples R China.;Zhang, WH (通讯作者),Fudan Univ, Dept Infect Dis, Huashan Hosp, Shanghai, Peoples R China.;Zeng, QL (通讯作者),Zhengzhou Univ, Dept Infect Dis & Hepatol, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.

HEPATOLOGY INTERNATIONAL, 2022; 16 (3): 691